Loading, please wait ...


News Analytics

7b691378ac10d8794d826e78bbd16159.
[1] ClinicalTrials.gov Identifier: NCT03439670 [2] Press release “Santhera and ReveraGen Announce Positive and Statistically Highly Significant Topline Results with Vamorolone in Pivotal VISION-DMD Study”, June 1, 2021, link About VISION-DMD VISION-DMD is a 48-week Phase 2b study designed as a pivotal trial to demonstrate efficacy and safety of vamorolone (2 and 6 mg/kg/day) versus prednisone (0.75 mg/kg/day) and placebo in 121 ambulant boys ...
Google

Subject Matter

  • Healthcare 57.38%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 42.62%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions